Charles, B.G., Schneider, J.J., Norris, R.L.G., and Ravenscroft, P.J. 1987. Temelastine does not affect theophylline pharmacokinetics in normal subjects, Brit. J. clin. Pharmacol., 24, 673-675
Kwon, K.I. and Bourne, D.W.A. 1987. Physiological pharmacokinetic model for distribution and elimination of tenoxicam, Int.J.Pharm., 37, 219-226
Bourne, D.W.A. and Hampton, E.M. 1988. Modeling and Analysis of Pharmacokinetic Data Using Multi-Forte and Boomer, Second Annual Symposium - Frontiers of Pharmacokinetics and Pharmacodynamics, Little Rock AR, 12-14 October
Clarke, C.R., Short, C.R., Bourne, D.W.A., and Usenik, E.A. 1989. Subcutaneously implanted tissue chambers -- a pharmacokinetic study, J. Vet. Pharmacol. Therap., 12, 312-321
Graves, N.M., Homes, G.B., Kriel, R.L., Jones-Saete, C., Ong, B. and Ehresman, D.J. 1989. Relative Bioavailability of Rectally Administered Phenobarbital Solution, DICP, Ann. Pharmacother., 23, 565-568
Ho, K.Y., Weissberger, A.J., Stuart, M.C., Day, R.O. and Lazarus, L. 1989. The Pharmacokinetics, Safety and Endocrine Effects of Authentic Biosynthetic Human Growth Hormone in Normal Subjects, Clin. Endocrin., 30, 335-345
Ismail, Z., Triggs, E.J., Smithurst, B.A., and Parke, W. 1989. The pharmacokinetics of amiloride-hydrochlorothiazide combination in the young and elderly, Eur. J. Clin. Pharmacol., 37, 167-171
Casto, D.T., Schnapf, B.M., Clotz, M.A. 1990. Lack of effect of short-term passive smoking on the metabolic disposition of theophylline, Eur. J. Clin. Pharmacol., 39, 399-402
Chen, G., Griffin, M., Poyer, J.L., McCay, P.B. and Bourne, D.W.A. 1990 HPLC procedure for the pharmacokinetic study of the spin-trapping agent, α-phenyl-N-tert-butyl nitrone (PBN), Free Radical Biology and Medicine, 9(2), 93-99
Hampton, E.M., Hrdlicka, K. and Bourne, D.W.A. 1991. Comparison of MS-DOS and Macintosh pharmacokinetic analysis programs using a two-compartment, two-infusion dosing scheme, Clin. Pharm., 10, 206-209
Paap, C.M., Nahata, M.C., Mentser, M.A., Mahan, J.D., Puri, S.K. and Hubbard, J.W. 1991 Pharmacokinetics of cefotaxime and its active metabolite in children with renal dysfunction, Antimicrob Agents Chemother., 35(9) 1879-1883
Markowsky, S.J., Zimmerman, C.L., Tholl, D., Soria, I. and Castillo, R. 1991. Methotrexate Disposition Following Disruption of the Blood-Brain Barrier, Therapeutic Drug Monitoring, 13, 24-31
Kim, H.C., McMillan, C.W., White, G.C., Bergman, G.E., Horton, M.W., and Saidi, P. 1992 Purified Factor IX Using Monoclonal Immunoaffinity Technique: Clinical Trials in Hemophilia B and Comparison to Prothrombin Complex Concentrates, Blood, 79(3) 568-57
Fan-Havarda, P., Koshya, Z., Baisa, R.M., Smith, C. and Eng, R.H.K. 1993 Effect of morphine or phenobarbital on teicoplanin elimination pharmacokinetics, Journal of Antimicrobial Chemotherapy, 32 101-108
Paap, C.M. and Nahata, M.C. 1993 The relation between type of renal disease and renal drug clearance in children, European Journal of Clinical Pharmacology, 44(2) 195-197
Pallapies, D., Peskar, B.A., Brune, K. and Geisslinger, G. 1994 Effects on platelet functions and pharmacokinetics of azapropazone and ketorolac tromethamine given as single parenteral doses, Br J Clin Pharmacol., 37(4) 335-339
Dachman, W.D., Adubofour, K.O., Bikin, D.S., Johnson, C.H., Mullin, P.D. and Winograd, M. 1994 Cimetidine-induced rise in praziquantel levels in a patient with neurocysticercosis being treated with anticonvulsants, The Journal of infectious Disease, 169 689-91
Walker, J.L., Clarke, C.R. , Hague, C.M., Bourne, D.W. and Lessley, B.A. 1994 Effects of localized Pasteurella haemolytica infection on erythromycin-binding properties of bovine alpha-1-acid glycoprotein, albumin, serum, and tissue chamber fluids, Antimicrob Agents Chemother., 38(10) 2392-2397
Kobayashi, K., Vokes, E.E., Vogelzang, N.J., Janish, L., Soliven, B. and Ratain, M.J. 1995 Phase I study of suramin given by intermittent infusion without adaptive control in patients with advanced cancer, Journal of Clinical Oncology, 13 2196-2207
Lau, C.E., Ma, F., Wang, Y. and Smith, C. 1996 Pharmacokinetics and bioavailability of midazolam after intravenous, subcutaneous, intraperitoneal and oral administration under a chronic food-limited regimen: relating DRL performance to pharmacokinetics, Psychopharmacology, 126(3) 241-248
Roder, J.D., Chen, C.L., Chen, H. and Sangiah, S. 1996 Bioavailability and pharmacokinetics of ibuprofen in the broiler chicken, Journal of Veterinary Pharmacology and Therapeutics, 19(3) 200-204
Manduru, M., Mihm, L.B., White, R.L., Friedrich, L.V., Flume, P.A. and Bosso, J.A. 1997 In vitro pharmacodynamics of ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients, Antimicrob. Agents Chemother., 41(9) 2053-2056
Polikandritou Lambros, M., Bourne, D.W.A., Abbas, S.A., and Johnson, D.L. 1997 Disposition of aerosolized liposomal amphotericin B, Journal of Pharmaceutical Sciences, 86(9) 1066-1069
Kwon, K-I. and Bourne, D.W.A. 1997 Gastrointestinal absorption of phenytoin from an oil-in-water microemulsion, Archives of Pharmacal Research, 20(5) 480-485
Browne, G.S., Nelson, C., Nguyen, T., Ellis, B.A., Day, R.O. and Williams, K.M. 1999 Stereoselective and substrate-dependent inhibition of hepatic mitochondrial β-oxidation and oxidative phosphorylation by the non-steroidal anti-inflammatory drugs ibuprofen, flurbiprofen, and ketorolac, Biochemical Pharmacology, 57(7) 837-844
Hakman, M. and Groth, T. 1999 Object-oriented biomedical system modeling-The Rationale, Computer methods and programs in biomedicine, 59(1) 1-17
Rusckowski, M., Qu, T., Pullman, J., Marcel, R., Ley, A. C., Ladner, R.C., and Hnatowich, D.J. 2000 Inflammation and Infection Imaging with a 99mTcNeutrophil Elastase Inhibitor in Monkeys, J NucI Med, 41 363-374
Alberts, M.K., Clarke, C.R., MacAllister, C.G., and Homer, L.M. 2000 Pharmacokinetics of acetazolamide after intravenous and oral administration in horses, American Journal of Veterinary Research 61(8) 965-968
IIIa, E.B., Lehenbauerb, T.W. and Sangiah, S. 2000 Oral pharmacokinetics of fenbendazole in llamas, South American Camelids, Small Ruminant Research, 37(3) 209-214
White, R.L., Friedrich, L.V., Manduru, M., Mihm, L.B. and Bosso, J.A. 2001 Comparative in vitro pharmacodynamics of imipenem and meropenem against ATCC strains of Escherichia coli, Staphylococcus aureus and Bacteroides fragilis, Diagnostic microbiology and infectious disease, 39(1) 39-47
Kilica, K., Sproule, B.A., Turksen, I.B. and Naranjo, C.A. 2002 Fuzzy system modeling in pharmacology: an improved algorithm, Fuzzy Sets and Systems, 130(2) 253-264
Kilic, K., Sproule, B.A., Turksen, I.B. and Naranjo, C.A. 2004 Pharmacokinetic application of fuzzy structure identification and reasoning, Information Sciences, 162(2) 121-137
Gilmour, M.A., Clarke, C.R., MacAllister, C.G., Dedeo, J.M., Caudell, D.L., Morton, R.J. and Pugh, M. 2005 Ocular penetration of oral doxycycline in the horse, Veterinary Ophthalmology, 8(5) 331-335
Durisova, M. and DedÃk, L. 2005 New Mathematical Methods in Pharmacokinetic Modeling, Basic & Clinical Pharmacology & Toxicology, 96(5) 335-342
Homer, L.M., Clarke, C.R. and Weingarten, A.J. 2005 Effect of dietary fat on oral bioavailability of tepoxalin in dogs, Journal of Veterinary Pharmacology and Therapeutics, 28(3) 287-291
Pizon, A.F., Becker, C.E. and Bikin, D. 2007 The Clinical Significance of Variations in Ethanol Toxicokinetics, J. Medical Toxicology, 3(2), 63-72
Maxwell, L.K., Bentz, B.G., Bourne, D.W.A. and Erkert, R.S. 2008 Pharmacokinetics of valacyclovir in the adult horse, Journal of Veterinary Pharmacology and Therapeutics, 31(4) 312-320
Goldsmith, M-R., Transue, T.R., Chang, D.T., Tornero-Velez, R., Breen, M.S. and Dary, C.C. 2010 PAVA: physiological and anatomical visual analytics for mapping of tissue-specific concentration and time-course data, Journal Of Pharmacokinetics and Pharmacodynamics, 37(3) 277-287
Material on this website should be used for Educational or Self-Study Purposes Only
Copyright © 2001-2010 David W. A. Bourne (david@boomer.org)